Alexandre Hermer, MS 2010, Director, Market Access & Pricing Europe, Oncology at GSK

Graduate of Grenoble Ecole de Management  in 2010, Alexandre Hermer was recently appointed Director, Market Access & Pricing Europe, Oncology at GSK, as of March this year.

With over 15 years of experience in the pharmaceutical industry and a degree from GEM’s Master in Biotechnology Management program, Alexandre has held senior roles at Pfizer, Shionogi, AstraZeneca, and Amicus Therapeutics.

A specialist in market access and pricing, he now brings his expertise to support GSK’s oncology efforts across Europe.

About de GSK

GSK, formerly GlaxoSmithKline, is a British multinational and one of the world’s top ten pharmaceutical companies. It was formed through the merger of Glaxo Wellcome and SmithKline Beecham in 2000.